Zimmer Biomet Holdings Inc (NYSE:ZBH)
| 114.98 Delayed Data As of Aug 11 |  -0.02 / -0.02%Today’s Change | 100.39 Today|||52-Week Range 149.17 | -6.71% Year-to-Date |
Latest ZBH News | Press Releases
Today’s Trading
| Previous close | 115.00 |
| Today’s open | 115.44 |
| Day’s range | 114.73 - 116.92 |
| Volume | 4 |
| Average volume (3 months) | 1,283,416 |
| Market cap | $23.8B |
Data as of 4:00pm ET, 08/11/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -4.98% |
| Earnings growth (next 5 years) | +5.53% |
| Revenue growth (last year) | +11.56% |
| P/E ratio | 83.3 |
| Price/Sales | 3.41 |
| Price/Book | 1.87 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| WSTWest Pharmaceutical ... | +0.18 | +0.05% |
| SAUHFStraumann Holding AG | +5.00 | +3.80% |
| PODDInsulet Corp | +1.59 | +0.61% |
| BAXBaxter International... | +0.07 | +0.12% |
Data as of 4:00pm ET, 08/11/2022
Financials
| Next reporting date | November 3, 2022 |
| EPS forecast (this quarter) | $1.57 |
| Annual revenue (last year) | $7.8B |
| Annual profit (last year) | $401.6M |
| Net profit margin | 5.12% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Warsaw, Indiana |
Forecasts
